Seasoned Private Investor Secures 19.99% Stake In Medical Company

In a move that has caught the attention of investors and industry observers alike, David E. Lazar, a seasoned private investor known for his keen eye for value, has recently made a significant investment in OpGen, Inc. (Nasdaq: OPGN). On March 25, 2024, Lazar acquired a substantial stake in the company, purchasing 200,000 shares of Series E Preferred Stock at an initial closing, with plans to acquire up to 3,000,000 shares. This transaction not only underscores Lazar's confidence in OpGen’s potential but also signals a pivotal moment for the company and its shareholders. $OpGen(OPGN.US)$